Insider filing · VTRS

Scott Andrew Smith bought $536K of Viatris (VTRS)

Executed May 12 2025, disclosed May 14 2025, 2 days later.

Over the 21 trading sessions from the disclosed entry session (May 14 2025), the stock returned +5.1% (delay-adjusted); from the execution session (May 12 2025), +2.3%. Derived: entry at the session's open, exit at the close 20 sessions later.

SS Scott Andrew Smith Chief Executive Officer profile →

Scott Andrew Smith (Chief Executive Officer) filed 2 Form 4 reports in the past 24 months (2 purchases, 0 sales), most often in Viatris Inc. (VTRS). Across 2 priced purchase filings, the average 21-session return was +3.4% from execution and +3.2% from disclosure (delay-adjusted; derived). The largest single filing was $536K of VTRS (60,000 sh × $8.94, as filed), executed May 12 2025.

VTRS Viatris Inc. VTRS · Healthcare · 9 filings in 24 months ticker →

Healthcare · Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, A…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→